| RESERVED AREA | LANGUAGE

Lung Cancer Study Group

World Cancer Day – TVI

The Director of the Pneumology Service at the IPO in Lisbon begins by mentioning that “we still do not have screening for lung cancer, one of the five most common cancers in Portugal and the one that currently kills the…

Read More

News in the treatment of patients with no vested genetic changes

The last round table of the Autumn Meeting, entitled “News in NSCLC with Actionable Genetic Changes”, was moderated by several experts, including Dr. Marta Soares. By way of summary, the oncologist at IPO Porto states that in this session “new…

Read More

News in the treatment of patients with no vested genetic changes

Dr. Fernanda Estevinho closed the “Round Table: New developments in the treatment of patients without Actionable Genetic Changes”, at the Autumn Meeting, by presenting the theme “Subsequent lines”. In this session, the oncologist at Pedro Hispano Hospital spoke about “second-line…

Read More

News in the treatment of patients with no vested genetic changes

The “Round Table: News in the treatment of patients without planetic genetic changes” had as a speaker Dr. Fernando Barata, from the Coimbra Hospital and University Center (Chuc). The expert presented the topic “First Line”, where he addressed the “State…

Read More

Round Table: News in Early NSCLC Disease

We close the interviews at the “Round Table: What’s New in Early NSCLC Disease”, from the Autumn Meeting, with comments from Dr. Catarina Travancinha, radioncologist at the CUF Oncology Institute, in Lisbon. The specialist spoke about the “Role of radiotherapy”,…

Read More

Merry Christmas

The Lung Cancer Study Group (GECP) wishes you a Merry Christmas and reminds you that prevention is essential, not only during the festivities, but also throughout the year. Health is a valuable gift, and taking care of it is an…

Read More

Resectability conditions

Dr. João Eurico Reis, thoracic surgeon at Centro Hospitalar Universitário de Lisboa Central (CHULC), was the second speaker at the “Round Table: News in Early NSCLC Disease”, at the Autumn Meeting, having presented the topic “Resectability conditions” . “It was…

Read More

Round Table: News in Early NSCLC Disease

Dr. Telma Sequeira, pulmonologist at the IPO in Lisbon, was one of the speakers at the “Round Table: What’s New in Early NSCLC Disease”, at the Autumn Meeting, presenting the topic “Neoadjuvant and adjuvant treatment”. The pulmonologist highlights that “the…

Read More

Course 2: GECP clinical trials

The first day of the autumn meeting of the Lung Cancer Study Group (GECP) was also marked by the “Course 2: Clinical Tests of the initiative of GECP,” Coordinated by Prof. Constança Coelho, Chief Scientific Officer, from X2 Science Solutions….

Read More

Assessment of Outcomes Research Technologies

We remember the Autumn Meeting by sharing the interview with Prof. Julian Perelman, one of the trainers of “Course 1: Assessment of Outcomes Research Technologies”. The specialist in Health Economics presented the topic “Economic evaluation in health”, the aim of…

Read More
©2022 Copyright GECP